Axcelis Technologies, Inc. (NASDAQ:ACLS) Shares Sold by Massmutual Trust Co. FSB ADV

Massmutual Trust Co. FSB ADV lowered its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 22.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 723 shares of the semiconductor company’s stock after selling 207 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in Axcelis Technologies were worth $81,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. Norges Bank acquired a new stake in Axcelis Technologies during the 4th quarter valued at approximately $57,105,000. Reinhart Partners LLC. bought a new position in Axcelis Technologies during the 1st quarter worth approximately $37,871,000. Jackson Square Partners LLC bought a new position in Axcelis Technologies during the 4th quarter worth approximately $42,892,000. Westfield Capital Management Co. LP bought a new position in Axcelis Technologies during the 3rd quarter worth approximately $40,425,000. Finally, Qube Research & Technologies Ltd bought a new position in Axcelis Technologies during the 3rd quarter worth approximately $23,445,000. Institutional investors and hedge funds own 89.98% of the company’s stock.

Axcelis Technologies Price Performance

ACLS opened at $137.68 on Friday. The stock has a market cap of $4.48 billion, a price-to-earnings ratio of 18.19, a PEG ratio of 3.41 and a beta of 1.54. Axcelis Technologies, Inc. has a 1 year low of $93.77 and a 1 year high of $201.00. The company has a current ratio of 4.00, a quick ratio of 2.87 and a debt-to-equity ratio of 0.05. The stock has a fifty day moving average price of $114.98 and a 200 day moving average price of $118.35.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings results on Wednesday, May 1st. The semiconductor company reported $1.57 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.31. Axcelis Technologies had a return on equity of 30.22% and a net margin of 22.16%. The company had revenue of $252.37 million during the quarter, compared to analysts’ expectations of $242.55 million. Analysts forecast that Axcelis Technologies, Inc. will post 6.41 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a report on Friday, May 3rd. B. Riley lifted their target price on Axcelis Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday. Craig Hallum upgraded Axcelis Technologies from a “hold” rating to a “buy” rating and set a $130.00 price target on the stock in a research report on Friday, May 3rd. Finally, Benchmark lowered their price target on Axcelis Technologies from $180.00 to $170.00 and set a “buy” rating on the stock in a report on Friday, May 3rd. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Axcelis Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $173.00.

Insiders Place Their Bets

In related news, Director John T. Kurtzweil sold 1,200 shares of the stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $114.42, for a total transaction of $137,304.00. Following the completion of the sale, the director now owns 33,146 shares in the company, valued at approximately $3,792,565.32. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.43% of the company’s stock.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.